chr22-46219983-T-C
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_005036.6(PPARA):āc.680T>Cā(p.Val227Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00364 in 1,614,026 control chromosomes in the GnomAD database, including 145 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ). Another nucleotide change resulting in same amino acid change has been previously reported as Likely benignin UniProt.
Frequency
Consequence
NM_005036.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PPARA | NM_005036.6 | c.680T>C | p.Val227Ala | missense_variant | 7/9 | ENST00000407236.6 | NP_005027.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PPARA | ENST00000407236.6 | c.680T>C | p.Val227Ala | missense_variant | 7/9 | 1 | NM_005036.6 | ENSP00000385523 | P1 | |
PPARA | ENST00000402126.1 | c.680T>C | p.Val227Ala | missense_variant | 5/7 | 1 | ENSP00000385246 | P1 | ||
PPARA | ENST00000493286.1 | n.890T>C | non_coding_transcript_exon_variant | 6/6 | 1 |
Frequencies
GnomAD3 genomes AF: 0.00500 AC: 760AN: 152080Hom.: 17 Cov.: 32
GnomAD3 exomes AF: 0.0112 AC: 2820AN: 251378Hom.: 75 AF XY: 0.00915 AC XY: 1243AN XY: 135870
GnomAD4 exome AF: 0.00349 AC: 5104AN: 1461828Hom.: 127 Cov.: 31 AF XY: 0.00327 AC XY: 2381AN XY: 727222
GnomAD4 genome AF: 0.00501 AC: 763AN: 152198Hom.: 18 Cov.: 32 AF XY: 0.00595 AC XY: 443AN XY: 74414
ClinVar
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 31, 2019 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
PPARA-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jan 27, 2020 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at